Tech Company Inital Public Offerings
Dermata Therapeutics IPO
Dermata Therapeutics, operating out of San Diego, debuted as a public company on 8/13/2021.
Transaction Overview
Company Name
Announced On
8/13/2021
Transaction Type
IPO
Amount
$180,000,000
Proceeds Purpose
Use of proceeds for the Dermata Therapeutics IPO are outlined in the company's S1 filing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
3525 Del Mar Heights Rd. 322
San Diego, CA 92130
USA
San Diego, CA 92130
USA
Phone
Website
Email Address
Overview
Dermata is a development-stage biotechnology company founded in late 2014 focused on making major advancements in the treatment of serious diseases treated by dermatologists, with a focus on inflammation and immunology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gerry Proehl
Chief Financial Officer
Thomas Insley
Vice President
Laura Weston
VP - Bus. Development
Chris Nardo
VP - General Counsel
Hazel Aker
VP - Product Management
Warren Hall
VP - Regulatory Affairs
Maria Bedoya Toro Munera
Browse more venture capital transactions:
Prev: 8/13/2021: Visus Therapeutics venture capital transaction
Next: 8/13/2021: Graphite venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on funding rounds that are announced publicly. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs